Dec 19, 2024, 02:16 | Blog

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research - NCI Division of Cancer Prevention

NCI Division of Cancer Prevention shared a post on LinkedIn: “New Funding Opportunity! Through this…

Dec 16, 2024, 16:24 | Blog

Omnia Korani: KELIM Score as a predictive and prognostic marker of Platinum Sensitivity in locally advanced Epithelial Ovarian Cancer

Omnia Korani, Assistant Lecturer at National Cancer Institute, posted on LinkedIn: "Honored to share that…

Dec 10, 2024, 11:19 | Blog

Women with severe types of endometriosis have a higher risk of ovarian cancer

Endometriosis is a condition where tissue similar to the uterine lining grows outside the uterus,…

Dec 7, 2024, 02:29 | Blog

The OVATION 2 Study and the Novel Immunotherapy IMNN-001 for Ovarian Cancer - IMUNON

IMUNON posted on LinkedIn: "ICYMI, our CEO Dr. Stacy Lindborg and gynecologic oncologist Dr. Premal…

Dec 4, 2024, 23:03 | Blog

Supporting essential services year-round with no woman left behind - World Ovarian Cancer Coalition

World Ovarian Cancer Coalition shared the following from the on LinkedIn: “In times of global…

Dec 3, 2024, 17:07 | Insight

The Efficacy and Safety of Mirvetuximab Soravtansine in Recurrent Platinum-Sensitive Ovarian Cancer - Annals of Oncology

Annals of Oncology shared a recent article by A. Alvarez Secord on X: "New article…

Dec 3, 2024, 05:11 | Blog

Tullia Bruno: Summary of our work presented at Multiomics 2024

Tullia Bruno, Assistant Professor at the University of Pittsburgh, posted the following on X: “What…

Dec 2, 2024, 19:11 | Blog

OCRF ambassador Suki Paddington shares the story of her mum's experience with ovarian cancer

Ovarian Cancer Research Foundation posted on LinkedIn: "In a powerful article, OCRF ambassador Suki Paddington…

Dec 2, 2024, 07:40 | Blog

Caitlin Delaney: I am launching my fundraiser for off-label treatments which will hopefully extend my life

Caitlin Delaney, Chair of the National Patient Advisory Committee, Patient-Partnered Research at VCCC Alliance and…

Nov 30, 2024, 18:30 | Insight

Young Kwang Chae: Nivolumab/Ipilimumab can be effective in select non-epithelial ovarian cancer

Young Kwang Chae, Associate Professor of Medicine, medical oncologist, and physician-scientist at Northwestern University’s Feinberg…

Nov 26, 2024, 15:49 | Insight

Five articles suggested by Yüksel Ürün

Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey.…

Nov 24, 2024, 16:49 | Blog

Zara Lawless: Building Stronger Connections for Breast and Ovarian Cancer Research

Ovarian Cancer Research Foundation (OCRF) shared a post by Zara Lawless on LinkedIn, adding: "This…

Nov 23, 2024, 12:46 | Blog

Isabelle Ray-Coquard: HIPEC in ovarian cancer - a dream or a reality?

Isabelle Ray-Coquard, Medical Oncologist at Léon Bérard Center, shared on LinkedIn: “HIPEC in ovarian cancer…

Nov 22, 2024, 09:56 | Blog

Miriam Mutebi about Breast Cancer Risk Factors

Miriam Mutebi, Breast Surgical Oncologist and Assistant Professor in the Department of Surgery at the…

Nov 20, 2024, 20:27 | Insight

HIPEC improves overall survival in recurrent epithelial ovarian cancer

Pramesh CS, Director at Tata Memorial Hospital, shared a recent article by Jean-Marc Classe on…

Nov 19, 2024, 20:55 | Blog

Rawia Mohamed: Updates and Insights on MMR in Colorectal Cancer

Rawia Mohamed, Head of the Anatomical Pathology Department at Burjeel Medical City, shared a post…

Nov 18, 2024, 18:36 | Insight

Uncovering mechanisms of immune evasion in Ovarian Cancer

Steven Artandi, Laurie Kraus Lacob Director of the Stanford Cancer Institute, shared an article by…

Nov 18, 2024, 17:31 | Blog

Audra Moran: Helene Harris Memorial Trust International Forum on Ovarian Cancer

Audra Moran, President and CEO at Ovarian Cancer Research Alliance, shared a post on LinkedIn:…

Nov 11, 2024, 17:40 | Blog

NCCN Expands Resources for Genetic and Familial Cancer Risk Assessment

National Comprehensive Cancer Network (NCCN) posted on LinkedIn: “NCCN expands two major resources to help…

Nov 6, 2024, 20:29 | Celebrities

Shannon Miller and Ovarian Cancer: How She Went Against, How She Survived, and More

Shannon Miller is a celebrated American gymnast, widely regarded as one of the sport's greatest…

Nov 4, 2024, 15:01 | Insight

Tumor-derived cytokines create microenvironments that enable ovarian cancer treatment evasion

Cancer Research Institute shared a post on LinkedIn: "Each year, approximately 300,000 people are diagnosed with…

Nov 2, 2024, 19:53 | Blog

Rahul Gosain: The current treatment landscape/algorithm for Ovarian Cancer with Martina Murphy

Rahul Gosain, Co-Host of the Oncology Brothers podcast, shared on LinkedIn: "Gynecological Oncology: with Martina…

Oct 27, 2024, 13:01 | Blog

OCRF supporter funds are currently powering 16 research projects in labs across Australia

Ovarian Cancer Research Foundation (OCRF) shared a post on LinkedIn: "Look at these frocks! This Frocktober…

Oct 27, 2024, 11:51 | Blog

Sid Yadav: CDK4/6 inhibitors in gynecologic cancers

Sid Yadav, Breast and GYN Oncologist in Women’s Cancer Program at Mayo Clinic Comprehensive Cancer…

Oct 23, 2024, 14:53 | Blog

The meeting report from the International Dialogue on Ovarian Cancer - Annals of Research in Oncology

Annals of Research in Oncology shared a post on LinkedIn: ''Developments in ovarian cancer research!…

Oct 22, 2024, 17:28 | Celebrities

Kathy Bates Ovarian and Breast Cancer: How She Went Against, How She Survived, and More

Kathy Bates is a renowned American actress, celebrated for her Oscar-winning performance in "Misery" and…

Oct 21, 2024, 14:53 | Blog

Susana Banerjee: ENGOTov60/RAMP201 phase 2 primary results in low grade serous ovarian cancer

Susana Banerjee, Consultant Medical Oncologist, Research Lead for the Gynaecology Unit at The Royal Marsden…

Oct 20, 2024, 11:13 | Blog

Implementation of the ESMO Guidelines in real clinical settings

ESMO shared a post on X: "Missed the live event? Watch the recording and download the…

Oct 17, 2024, 09:43 | Insight

Anixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical Trial

Anixa Biosciences, Inc., a biotechnology firm focused on cancer treatment and prevention, has announced the…

Oct 16, 2024, 13:19 | Blog

Aisha Mustapha: Supporting Zainab Shinkafi-Bagudu at 2024 IGCS-IGCAN

Aisha Mustapha, Consultant Obstetrician Gynaecologist at Ahmadu Bello University, shared a post on X: "At…

Oct 12, 2024, 13:43 | Blog

Brian Gabrielli and Kristen Radford are raising funds for the Ovarian Cancer Research Foundation - Mater Research

Mater Research shared a post on LinkedIn: "Professor Brian Gabrielli and Professor Kristen Radford swapped their…

Oct 11, 2024, 14:34 | Blog

Giuseppe Caruso: TOO is an easy-to-use composite quality measure that is associated with survival in advanced-stage ovarian cancer

Giuseppe Caruso, Gynecology Oncology Specialist at European Institute of Oncology, shared a post a post…

Oct 11, 2024, 12:52 | Blog

Discovering spatial biology in endometriosis research - European Association for Cancer Research

European Association for Cancer Research made the following post on LinkedIn: “Discover one researcher’s journey…

Oct 9, 2024, 16:23 | Blog

ESMO Gynaecological Cancers Congress 2025

The ESMO Gynaecological Cancers Congress 2025 will be held in Vienna, Austria on June 19-21,featuring…

Oct 8, 2024, 09:59 | Blog

The Every Woman Study Low and Middle-Income Edition headline results will launch at IGCS2024

World Ovarian Cancer Day & WOCCoalition shared a post on X: "Big news! The Every Woman…

Oct 7, 2024, 11:13 | Blog

Meg Eckenroad: The Urgent Need for Ovarian Cancer Breakthroughs

Meg Eckenroad shared an article on LinkedIn: ''Innovation Stalled: The Urgent Need for Ovarian Cancer Breakthroughs.…

Oct 7, 2024, 09:14 | Blog

Khoren Amirkhanyan: Participated in two enriching programs by ESMO

Khoren Amirkhanyan, Oncology Resident, National Center of Oncology of Armenia, shared a post on LinkedIn:…

Oct 1, 2024, 18:18 | Insight

Elizabeth McKenna: Early Detection of Ovarian Cancer Using Cell-Free DNA Fragmentomes and Protein Biomarkers

Elizabeth McKenna shared a post on X about a recent paper by Jamie Medina et…

Oct 1, 2024, 15:46 | Dialogues

Résilience et rétablissement: le combat de Guitta Chartouni contre le cancer de l'ovaire de stade 4

In this episode, hosted by Tatev-Sargsyan Lefort, stage 4 ovarian cancer survivor Guitta Chartouni, shares…

Sep 28, 2024, 20:20 | Blog

Kanika Batra Modi: Insightful moments at various conferences across the country

Kanika Batra Modi, Senior Consultant and Fellowship Director, Gynaecologic Oncology, Max Hospital, shared a post on…

Sep 28, 2024, 16:02 | Blog

Jacqueline Ogingo: Let’s stop addressing women’s health in silos

Jacqueline Ogingo, Program Manager at KILELE Health, shared the following on LinkedIn: “A woman from a…

Sep 27, 2024, 19:11 | Blog

Esra Bilir: Predictive value of homologous recombination deficiency in primary tubo-ovarian high-grade serous carcinoma

Esra Bilir shared a post on LinkedIn: "Thrilled to share the publication of our protocol,…

Sep 26, 2024, 03:08 | Blog

Shahrin Ahmed: Five gynaecological cancer symptoms

Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared a post on X: "It…

Sep 25, 2024, 14:10 | Blog

The latest issue of Annals of Research in Oncology is now available

Annals of Research in Oncology shared a post on LinkedIn: ''The latest issue of Annals…

Sep 22, 2024, 04:43 | Blog

Mechanisms of Ovarian Cancer progression and metastasis by Joanna Burdette - NCI Division of Cancer Biology

NCI Division of Cancer Biology shared a post on X: "Dr. Joanna Burdette, University of…

Sep 17, 2024, 01:02 | Blog

Monika Pansari: Empowering women with advanced surgical approaches to breast & ovarian cancer

Monika Pansari posted the following on LinkedIn: “Dr. Monika Pansari recently delivered an insightful session…

Sep 15, 2024, 15:20 | Insight

Novel ADC AZD8205 demonstrates manageable safety profile and preliminary efficacy in first-in-human trial

The antibody-drug conjugate (ADC) puxitatug samrotecan (AZD8205) demonstrated a manageable safety profile consistent with similar…

Sep 13, 2024, 14:17 | Opinion

Sendurai Mani: A walk to bring awareness for Cancer and early detection to save lives

Sendurai Mani shared on Linkedin: ''On September 7th, 2024, in honor of cancer survivors, to…

Sep 9, 2024, 15:51 | Blog

4 symptomes that can improve the diagnosis of ovarian cancer by Shahrin Ahmed

Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared a post on X: "The…

Sep 7, 2024, 14:50 | Blog

Medigene Announces U.S. FDA Clearance of IND Application for MDG1015 for Multiple Solid Tumor Indications

Medigene AG, an oncology platform company focused on the research and development of T cell…

Sep 6, 2024, 17:24 | Blog

We can’t always anticipate what happens to those we love but we can make a plan

American Cancer Society (ACS) shared on LinkedIn: “Lindsay O., an American Cancer Society volunteer, lost…

Sep 5, 2024, 14:50 | Insight

UAE’s first ovarian preservation procedure on a 7-year-old patient with ALL

MedEdge MEA shared a post on LinkedIn: “The Abu Dhabi Stem Cells Center (ADSCC) has…

Sep 5, 2024, 00:05 | Blog

September is Gynecologic Cancer Awareness Month - NRG Oncology

NRG Oncology made the following post on X: "September is Gynecologic Cancer Awareness Month, which includes…

Sep 4, 2024, 16:13 | Blog

September is Gynecologic Cancer Awareness Month 2024 - Meno Martha International Menopause Directory

Meno Martha International Menopause Directory shared a post on X: ''Gynecologic Cancer Awareness Month 2024.…

Sep 4, 2024, 11:18 | Insight

ESGO-ESHRE-ESGE guidelines for fertility-sparing treatment and follow-up in patients with cervical and ovarian cancer and borderline ovarian tumours

ESGO made the following post on X: "Published last night in The Lancet Oncology. Paper: ESGO-ESHRE-ESGE…

Sep 4, 2024, 03:51 | Blog

Antonio Giordano: National Gynecologic Cancer Awareness Month serves as a beacon, guiding us as a society to take actionable steps against these diseases

Antonio Giordano, President of Sbarro Health Research Organization, posted the following on LinkedIn: “National Gynecologic…

Sep 2, 2024, 17:54 | Blog

Today is the start of Gynecologic Cancer Awareness Month! - Uterine Cancer Awareness Network

Uterine Cancer Awareness Network made the following post on X: "Today is the start of Gynecologic…

Sep 2, 2024, 17:22 | Insight

Carmine Valenza: The role of gBRCA-PV in post-PARPi myeloid neoplasms, in patients with ovarian cancer

Carmine Valenza, MPH Student at Harvard T.H. Chan School of Public Health, shared a post…

Aug 26, 2024, 21:14 | Blog

Livnat Jerby: Applying spatial transcriptomics at subcellular resolution to 130 ovarian cancer tumors

Livnat Jerby, Assistant Professor at Stanford University, posted on X: "Our new paper is out…

Aug 21, 2024, 14:03 | Blog

$3 million research grant to Dana-Farber Cancer Institute and UT Health San Antonio to study BRCA therapy

Dana-Farber Cancer Institute shared on LinkedIn: "Scientists at Dana-Farber's Center for BRCA and Related Genes in…

Aug 15, 2024, 15:01 | Blog

Exciting Breakthrough in Early Detection of Aggressive Ovarian Cancer - World Ovarian Cancer Coalition

World Ovarian Cancer Coalition shared a post on LinkedIn: “Exciting Breakthrough in Early Detection of…

Aug 10, 2024, 13:30 | Insight

Susanna Greer: Unzipping truths behind BRCA

Susanna Greer shared on LinkedIn: "The focus of this week’s Cool Cancer Find comes from…

Aug 9, 2024, 16:01 | Blog

Re-sensitizing cancer to previously effective treatments - Ovarian Cancer Research Alliance

Ovarian Cancer Research Alliance shared on X: “The potential for re-sensitizing cancer to previously effective…

Aug 6, 2024, 14:09 | Blog

DeepHRD predicts HRD from routine biopsy slides

Elvina Almuradova, Medical Oncologist Ambassador at European School of Oncology, shared a post on X,…

Aug 6, 2024, 01:14 | Blog

First-Line Maintenance Strategies for Ovarian Cancer with Bevacizumab and PARP Inhibitors - EIOC

Excellence in Oncology Care (EIOC) shared on X: "Save the Date! Join our virtual journal…

Aug 5, 2024, 05:34 | Dialogues

Unlocking the Immune System: Dr. Levisetti on Cue Biopharma's New Biologics

Matteo Levisetti, M.D is chief medical officer of CUE Biopharma which is a clinical-stage biopharmaceutical…

Aug 4, 2024, 11:36 | Blog

Updates about federal funding for key ovarian and gynecologic cancer programs at CDC - Ovarian Cancer Research Alliance

Ovarian Cancer Research Alliance shared a post on X: "Get important updates about federal funding for…

Jul 31, 2024, 15:50 | Blog

Juan Cubillos-Ruiz: Iron chelation therapy unleashes innate immune responses that control Ovarian Cancer

Juan Cubillos-Ruiz, Associate Professor for Infection and Immunology at Well Corner Medicine, shared on X:…

Jul 31, 2024, 12:48 | Blog

Megan-Claire Chase: Cancer experience from a teenager's perspective

Megan-Claire Chase, A Patient Advocate, shared on LinkedIn: "As many of you know, I was…

Jul 21, 2024, 21:50 | Blog

Women with endometriosis have a significant increased risk of developing ovarian cancer

Huntsman Cancer Institute posted on X about recent paper by Jennifer Doherty et al., commenting: "A…

Jul 16, 2024, 15:29 | Insight

Delving into the topic of early detection for ovarian cancer with Sarah DeFeo and Gillian Hanley

Audra Moran, President and CEO at Ovarian Cancer Research Alliance (OCRA), shared on LinkedIn: “Fortune…

Jul 13, 2024, 15:20 | Blog

Rizwan Romee: CAR memory–like NK cells in ovarian cancer

Rizwan Romee, Associate Professor at Dana-Farber Cancer Institute, shared on X: "Excited to share this paper…

Jul 12, 2024, 23:39 | Blog

Itai Yanai: ‘Resistance continuum’ of resistant phenotypes of cancer cells

Itai Yanai, Professor at the Department of Biochemistry and Molecular Pharmacology at NYU, shared on…

Jul 7, 2024, 07:08 | Insight

Medigene AG Expands Patent Portfolio with the Patent Grant for NY-ESO-1/LAGE 1a Targeted T Cell Receptor in China

Medigene AG, an immuno-oncology platform company focusing on the discovery and development of T cell…

Jul 6, 2024, 14:18 | Blog

Zheng Wang: Tumor immune infiltration and prognosis in early breast cancer

Zheng Wang, Clinical Assistant Professor at Ruijin Hospital Affiliated to Shanghai Jiao Tong University, shared on…

Jul 6, 2024, 12:09 | Blog

An incredible outreach program organized by the Network of People Impacted by Cancer in Nigeria with Project PINK BLUE - Medicaid CF Programs

Quoting Medicaid CF Programs on X: "Throwback to the weekend where we were honored to…

Jul 1, 2024, 13:29 | Blog

Rodrigo Sánchez-Bayona: RWE study of ovarian cancer patients treated with PARP inhibitors at ESMO Gynaecological Cancers Congress 2024

Rodrigo Sánchez-Bayona, Medical Oncologist specialising in breast and gynecological cancers at 12 de Octubre University…

Jul 1, 2024, 12:34 | Blog

Ilaria Colombo: New targets and new drugs for the treatment of ovarian cancer at XXI MaNGO meeting

Ilaria Colombo, Medical Oncologist at MD. Drug Development and Gyne Cancer, posted on X: "Great…

Jun 29, 2024, 22:54 | Blog

Caitlin Delaney: The reality of living with a rare cancer

Caitlin Delaney, Chair of the National Patient Advisory Committee and Patient-Partnered Research at VCCC Alliance, shared…

Jun 24, 2024, 11:28 | Blog

Funding available in ovarian cancer research for mid-career physician scientists - Conquer Cancer Foundation

Conquer Cancer Foundation shared on LinkedIn: . "Deadline extended! Funding available in ovarian…

Jun 24, 2024, 10:34 | Insight

Susanna Greer: Opening the door to new treatments for cancer patients

Susanna Greer, Chief Scientific Officer at The V Foundation for Cancer Research, shared on LinkedIn:…

Jun 23, 2024, 18:37 | Blog

Monika Pansari: Positive transformation often lies on the other side

Monika Pansari, Senior Consultant Surgical Oncologist at Fortis Hospital, Bangalore posted on LinkedIn: "To those…

Jun 23, 2024, 13:36 | Blog

ESMO Daily Reporter article by Giovanni Scambia about Ginecological cancers

ESMO (European Society for Medical Oncology) shared on LinkedIn: …

Jun 20, 2024, 01:53 | Insight

Miguel Bronchud: ESMO recommends performing tumour NGS to detect tumour-agnostic alterations in patients with metastatic cancers

Miguel Bronchud, Co-Founder of Regenerative Medicine Solutions, shared on LinkedIn: “2024- ESMO of course recommends…

Jun 19, 2024, 12:33 | Blog

Maria Babak: How Bevacizumab is revolutionizing treatment for multiple cancers

Maria Babak shared a post by CityU iGEM on LinkedIn: "Discover how Bevacizumab, a powerful cancer…

Jun 14, 2024, 16:16 | Insight

Maximilian Strobl: Could adaptive therapy improve PARPi maintenance for ovarian cancer?

Maximilian Strobl, Postdoctoral Researcher at Moffitt Cancer Center and Research Institute, shared a post on…

Jun 14, 2024, 00:15 | Blog

Daria Afenteva: Poster session is ongoing at EACR2024 in Rotterdam!

Daria Afenteva, Doctoral Researcher at University of Helsinki, shared a post on X: "Poster session…

Jun 13, 2024, 01:46 | Insight

Dmitriy Zamarin: Submit your abstracts to the Biennial Rivkin-AACR Ovarian Cancer Research symposium!

Dmitriy Zamarin, Section Head of Gynecologic Medical Oncology at Icahn School of Medicine at Mount…

Jun 11, 2024, 15:36 | Blog

Jia Liu: Thrilled to share results from the Phase I/II clinical trial of dendrimer SN38

Jia Liu, Translational Lead, Early Phase Drug Development at The Kinghorn Cancer Centre and Conjoint…

Jun 10, 2024, 11:27 | Cancer Types

Primary Peritoneal Cancer: What patients should know about

Primary peritoneal cancer (PPC) is a rare and aggressive malignancy that originates in the peritoneum,…

Jun 5, 2024, 13:40 | Immune Oncology

Immunotherapy for Ovarian Cancer: A Growing Field

How Immunotherapy Works for Ovarian Cancer Immunotherapy represents a paradigm shift in the treatment of…

May 29, 2024, 14:37 | Blog

Antonio Giordano: 'International Dialogue on Ovarian Cancer, from Bench to Bedside' congress

Antonio Giordano, President of Sbarro Health Research Organization, posted the following on LinkedIn: "On May…

May 29, 2024, 07:57 | Insight

Khalid El Bairi: Don't forget to follow these wonderful oncologists, advocates, and researchers!

Khalid El Bairi, International Executive Council at NCODA shared a post on X: “Don't forget to…

May 26, 2024, 12:04 | Societies

Dee Sparacio: Join us and learn how social media improves practice, research and education!

Dee Sparacio, Ovarian Cancer Survivor, Author and Research Advocate, shared on X: "One week from…

May 23, 2024, 15:03 | Insight

Alexander Anderson: Our beautiful integrated Cell Systems paper led by the brilliant Maximilian Strobl

Alexander Anderson, Chair of Integrative Mathematical Oncology at Moffitt Cancer Center, shared on X: "Very…

May 22, 2024, 14:42 | Blog

eFFECTOR Therapeutics announces the initiation of an investigator-sponsored trial in collaboration with the Dana-Farber Cancer Institute

eFFECTOR Therapeutics shared a post on LinkedIn: "We are excited to announce the initiation of an…

May 22, 2024, 08:39 | Blog

Tanja Obradovic: ASCO just published guidelines for germline genetic testing panels

Tanja Obradovic shared on LinkedIn: "Great service to public and oncology community as ASCO just published…

May 17, 2024, 19:06 | Blog

Zainab Shinkafi-Bagudu: Global Coalition Urges World Health Leaders to Prioritise Ovarian Cancer in the Fight for Women's Health

Zainab Shinkafi-Bagudu shared on LinkedIn: “Global Coalition Urges World Health Leaders to Prioritise Ovarian Cancer in…

May 16, 2024, 16:51 | Insight

10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily

In the fast-growing field of oncology, we are witnessing significant advances in several treatment modalities…

May 16, 2024, 02:34 | Blog

Dr. Domenica Lorusso discussed the survival analysis of the PAOLA1 trial - International Journal of Gynecological Cancer

International Journal of Gynecological Cancer shared on LinkedIn: "New episode of Weekly Podcast Dr. Domenica…